- Business
- Churchill Capital Corp X Warrants (CCCXW) entitle holders to purchase one Class A ordinary share of Churchill Capital Corp X, a blank check company, at an exercise price of $11.50 per share; the warrants become exercisable 30 days after the completion of the company's initial business combination and expire five years thereafter, with no fractional warrants issued and cash redemption possible by the company under specified conditions. Churchill Capital Corp X, founded in 2024 and headquartered in New York, New York, focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses across any industry; it conducted its initial public offering on May 14, 2025, raising $414 million through units comprising one Class A ordinary share and one-quarter warrant, with separate trading of shares (CCCX) and warrants (CCCXW) commencing July 7, 2025, on the Nasdaq Global Market. In recent developments, Churchill Capital Corp X entered a definitive business combination agreement on September 8, 2025, with Infleqtion, a neutral-atom quantum technology company, valuing Infleqtion at a pre-money equity value of $1.8 billion and expected to deliver over $540 million in gross proceeds including cash from the trust account and a $125 million common stock PIPE from investors such as Maverick Capital and Morgan Stanley's Counterpoint Global; the companies submitted a confidential draft registration statement on Form S-4 to the SEC on October 29, 2025, with the transaction anticipated to close in the first quarter of 2026, subject to shareholder approval, regulatory clearances, and other conditions, positioning Infleqtion as the first publicly listed neutral-atom quantum technology firm under the ticker INFQ. The SPAC operates in the financial services sector under shell companies, targeting opportunities without specified geographic limitations or subsidiaries at present, and is led by Chairman, President, and CEO Michael S. Klein.